ABIO Financial Statements (ABIO)

Артген биотех (ИСКЧ)smart-lab.ru   2020 2021 2022 2023 2024   LTM ?
Report date 30.04.2021 05.05.2022 29.04.2023 26.04.2024 28.04.2025   28.04.2025
Currency RUB RUB RUB RUB RUB   RUB
Financial report URL  
Annual report URL  
Revenue, bln rub ? 1.08 1.18 1.14 1.37 1.52   1.52
Operating Income, bln rub 0.200 0.120 0.111 0.276 0.301   0.301
EBITDA, bln rub ? 0.205 0.155 0.164 0.347 1.15   1.15
Net profit, bln rub ? 0.073 0.012 0.046 0.169 0.215   0.215
OCF, bln rub ? 0.054 0.280 0.220 0.435 0.482   0.482
CAPEX, bln rub ? 0.086 0.153 0.218 0.204 0.100   0.100
FCF, bln rub ? 0.041 0.066 -0.042 0.191 0.185   0.185
Dividend payout, bln rub 0.085 0.111  
Dividend, rub/share ? 1 1.2  
Ordinary share dividend yield, % 0.0% 0.0% 1.6% 1.2% 0.0%   0.0%
Dividend payout ratio, % 0% 0% 185% 66% 0%   0
OPEX, bln rub 0.750 1.06 1.03 1.09 1.22   1.22
Amortization, bln rub 0.1 0.1 0.1   0.1
R&D, bln rub 0.005 0.080 0.030 0.010  
Employment expenses, bln rub 0.224 0.253 0.245 0.258 0.281  
Interest expenses, bln rub 0.027 0.051 0.049 0.052 0.091   0.091
Assets, bln rub 1.51 1.74 2.04 2.54 2.67   2.67
Net Assets, bln rub ? 0.194 0.234 0.341 0.424 0.407   0.407
Debt, bln rub 0.180 0.494 0.708 0.650 0.000   0.000
Cash, bln rub 0.100 0.193 0.202 0.544 0.503   0.503
Net debt, bln rub 0.08 0.30 0.51 0.11 -0.50   -0.50
Ordinary share price, rub 38.2 115.0 62.1 102.0 84.9   88.7
Number of ordinary shares, mln 75.0 85.0 92.6 92.6 92.6   92.6
Free Float, % 15.0% 21.7%   21.7%
Market cap, bln rub 2.86 9.78 5.75 9.45 7.86   8.22
EV, bln rub ? 2.94 10.1 6.26 9.56 7.36   7.72
Book value, bln rub -0.27 -0.31 -0.40 -0.38 -0.45   -0.45
EPS, rub ? 0.97 0.14 0.50 1.82 2.32   2.32
FCF/share, rub 0.55 0.78 -0.45 2.06 2.00   2.00
BV/share, rub -3.53 -3.64 -4.26 -4.06 -4.87   -4.87
EBITDA margin, % ? 18.9% 13.1% 14.4% 25.3% 75.7%   75.7%
Net margin, % ? 6.7% 1.0% 4.0% 12.3% 14.1%   14.1%
FCF yield, % ? 1.4% 0.7% -0.7% 2.0% 2.4%   2.3%
ROE, % ? 37.6% 5.1% 13.5% 39.9% 52.8%   52.8%
ROA, % ? 4.8% 0.7% 2.3% 6.7% 8.0%   8.0%
P/E ? 39.2 814.6 125.0 55.9 36.6   38.2
P/FCF 69.8 148.1 -136.9 49.5 42.5   44.4
P/S ? 2.64 8.28 5.06 6.90 5.17   5.41
P/BV ? -10.8 -31.6 -14.6 -25.1 -17.4   -18.2
EV/EBITDA ? 14.4 65.0 38.1 27.5 6.40   6.71
Debt/EBITDA 0.39 1.94 3.09 0.31 -0.44   -0.44
R&D/CAPEX, % 0.00% 3.27% 36.70% 14.71% 10.00%   0
CAPEX/Revenue, % 8% 13% 19% 15% 7%   7%
ABIO shareholders